Overview:
Although anti-VEGF therapies have advanced the management of nAMD and DME, limitations with their use – including the need for frequent injections and incomplete response for many patients – led to the development of newer anti-VEGF agents. In this program, expert faculty will share opportunities to improve the diagnosis of nAMD and DME, educate patients on their treatment options, and participate in team-based care for these patients.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Analyze the role of the optometrist in identifying and diagnosing nAMD
- Summarize optometrists’ responsibility in identifying and diagnosing DME
- Evaluate the impact of advanced therapies in the management of nAMD
- Analyze the impact of managing DME with advanced treatments
- Describe optimal strategies for collaborative multidisciplinary care and communication between optometrists and retina specialists
Veeral Sheth, MD, MBA, FASRS, FACS
Director of Clinical Research
University Retina and Macula Associates
Board Certified Ophthalmologist and Retinal Surgeon
Clinical Assistant Professor
University of Illinois at Chicago
Chicago, IL
Xiao Yi Zhou, MD
Assistant Professor of Opthamology and Visual Science
Assistant Professor of Pathology
University of Chicago
Chicago, IL
Dimitra Skondra, MD, PhD, FASRS
Professor of Ophthalmology and Visual Science at University of Chicago
Director, J. Terry Ernest Ocular Imaging Center
Founder/Leader, UChicago Retina Microbiome Team
Founder/Leader, UChicago Retina Big Data/Bioinformatics Team
Chicago, IL
Mathew MacCumber, MD, PhD
Professor and Research Director
Department of Ophthalmology
Rush University Medical Center
and Retina Specialist and
Research Director
Illinois Retina Associates
Chicago, IL
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, designates this activity for a maximum of 1.0 COPE credit.